PEDIATRICS Vol. 41 No. 1 January 1968, pp. 1-4
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diamond, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diamond, L. K.

PROTECTION AGAINST Rh SENSITIZATION AND PREVENTION OF ERYTHROBLASTOSIS FETALIS

Louis K. Diamond M.D.1

1 Department of Pediatrics, Harvard Medical School Children's Hospital Medical Center Boston, Massachusetts 02115

Rarely has it been our good fortune to have a disease recognized, its cause clearly determined, its treatment successfully developed to a great extent, and then its prevention found, all in one generation. It is gratifying to be able to review such a sequence of events, especially the latest advance. In 1932, we1 drew together and defined as a single entity, generally called erythroblastosis fetalis, four conditions previously described separately, namely late fetal death with erythroblastosis in the tissues, fetal hydrops, congenital anemia of the newborn, and icterus gravis neonatorum.In 1941, Philip Levine and coworkers2 astutely surmised that the disease resulted from immunization of the mother against a blood group factor of her infant and the development of hemolytic anemia in the baby from the transplacental passage of maternal antibodies.




This article has been cited by other articles:


Home page
 PediatricsHome page
H. A. Pearson
Replacement Transfusion as a Treatment of Erythroblastosis Fetalis, by Louis K. Diamond, MD, Pediatrics, 1948;2:520-524
Pediatrics, July 1, 1998; 102(1): 203 - 205.
[Abstract] [Full Text]